Marginal corneal ulcer, bilateral
ICD-10 H16.043 is a billable code used to indicate a diagnosis of marginal corneal ulcer, bilateral.
Marginal corneal ulcers are localized areas of corneal epithelial loss that occur at the limbus, the border between the cornea and the sclera. In bilateral cases, both eyes are affected, which can lead to significant discomfort, visual disturbances, and potential complications if left untreated. Clinically, patients may present with symptoms such as redness, tearing, photophobia, and blurred vision. The anatomy involved includes the cornea, which is crucial for light refraction and vision, and the conjunctiva and sclera, which provide structural support and protection. Disease progression can vary; if the ulcer is superficial, it may heal spontaneously, but deeper ulcers can lead to scarring and vision loss. Diagnostic considerations include a thorough eye examination, slit-lamp evaluation, and possibly cultures if an infectious etiology is suspected. The presence of underlying conditions such as dry eye syndrome, autoimmune diseases, or contact lens wear can exacerbate the condition, necessitating a comprehensive approach to management.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
H16.043 covers bilateral marginal corneal ulcers, which may arise from various causes including mechanical irritation, infections, or underlying systemic diseases. It is essential to differentiate this condition from other corneal ulcers and conjunctival disorders.
H16.043 should be used when both eyes exhibit marginal corneal ulcers. If only one eye is affected, the appropriate unilateral code (H16.041 or H16.042) should be selected based on the eye involved.
Documentation should include a detailed patient history, clinical examination findings, treatment plans, and follow-up assessments. Evidence of bilateral involvement and any underlying conditions should also be clearly noted.
